logo
2025 SF World Spirits Competition Crowns Top Extra Añejo Tequila

2025 SF World Spirits Competition Crowns Top Extra Añejo Tequila

Forbes24-05-2025

The Extra Añejo Tequila finalists from the 2025 SFWSC
Five Tequilas have been chosen as finalists for the World's Best Extra Añejo Tequila at the 2025 San Francisco World Spirits Competition. The SFWSC is one of the largest and most prestigious spirit judging events in the world. Its results are closely followed by consumers and the beverage industry. The Top Shelf 2025 Awards Gala, a highly anticipated event in the Tequila industry, will reveal the winner on November 9 at Hotel Nikko in San Francisco. Below are brief backgrounds and tasting notes on the finalists.
Cierto Tequila is an ultra-premium Tequila brand crafted by Master Distiller Enrique Fonseca at La Tequileña in Tequila. It is renowned for using mature, estate-grown Highland agave and traditional production methods. Cierto is prized for its smooth, complex flavor profile and claims to be free of additives.
The brand offers two main lines. The Private Collection emphasizes refined elegance and accessibility across its Blanco, Reposado, Añejo, and Extra Añejo expressions. The Reserve Collection represents a luxury tier with longer aging and a similar range of expressions. It is designed to showcase depth and richness, appealing to connoisseurs. Both lines consistently win medals in international spirit competitions, positioning Cierto as a benchmark for modern artisanal Tequila.
The Tequila is crafted using traditional methods and aged for over seven years in a mix of French and American oak barrels.
The Tequila is highly aromatic on the nose, showcasing roasted agave scents of salted caramel, vanilla, toasted oak, and gentle cinnamon. The palate is both refined and complex, revealing sweet agave, candied cherries, caramel, vanilla, aged leather, cinnamon, black pepper, and subtle herbal notes. The finish is long and sweet, with lingering hints of cherry syrup, caramel, and delicate traces of dried tobacco leaf.
Don Julio Tequila, located in Atotonilco el Alto, is one of Mexico's most iconic premium Tequila brands, founded in 1942 by Don Julio González. It uses hand-selected, mature Blue Weber agave and traditional slow-cooking methods to guarantee a smooth Tequila with layered, nuanced complexity. The portfolio features a range of expressions, from the crisp Blanco to the luxurious Ultima Reserva Extra Añejo. Recognized for pioneering luxury tequila, Don Julio has set a global standard for quality and craftsmanship.
The Tequila is aged for 36 months in a Solera-like system. It matures in bourbon barrels and finishes in Madeira wine casks.
The Tequila is aromatic and complex on the nose, featuring roasted agave notes of vanilla and caramel, dried and candied fruit—especially cherry—herbal green agave, and toasted oak notes with a slight minerality. It's fruity and sweet on the palate, with a nuanced, layered complexity that includes dark dried fruit, golden raisin, cherry, dried apricot, candied orange zest, honey, black pepper, and seasoned oak. The finish is long and sweet, with lingering honeyed agave and fruity notes.
Extra Añejo Tequila shots with lime and salt
El Tesoro Tequila is another iconic Mexican Tequila brand. Founded by Don Felipe Camarena in 1937, it's produced at La Alteña Distillery in Arandas in Jalisco's highlands. Known for preserving traditional methods, El Tesoro uses tahona-crushed agave, natural fermentation, and slow distillation to retain the full agave flavor. The Tequila is aged 4 to 5 years in ex-bourbon barrels made of American oak.
The Tequila is floral and aromatic on the nose, featuring roasted agave notes of caramel, butterscotch, vanilla, coffee, cinnamon, and slight mineral notes. The palate is rich and fruity, showcasing coffee, dark chocolate, dried fruits, roasted almonds, seasoned wood, and hints of herbal notes. The finish is long, with lingering fruity and caramel notes,
1800 is produced by Casa Cuervo. The Tequila matures for approximately five years in ex-bourbon barrels made of American oak and is then finished for a short period in French oak Cognac barrels.
The Tequila offers hints of vanilla, red fruits, a touch of cinnamon, and well-seasoned oak notes on the nose. It's rich and layered on the palate, showcasing roasted agave notes of caramel and vanilla intertwined with red fruits, subtle cinnamon, and a smooth, balanced oak presence alongside herbal and chocolate hints. The finish is long and elegant with lingering notes of mint chocolate, seasoned oak, and subtle caramel and vanilla flavors.
Don Fulano is crafted by Master Distiller Enrique Fonseca and blended by Sergio Mendoza at La Tequileña in Tequila. This Extra Añejo Tequila is aged for a minimum of five years in dark European oak and finished in Oloroso sherry casks. According to the company, the Tequila is 100% additive-free.
The nose is fruity and complex, featuring dried figs and apricots, complemented by subtle roasted agave notes of caramel and well-seasoned oak. It's spicy on the palate, showcasing allspice, cinnamon, pepper, caramel, vanilla, and agave flavors. The finish is long and sweet, with lingering caramel, chocolate, and spicy notes.
These exceptional Extra Añejo Tequilas demonstrate a range of maturation methods, finishing techniques, and cask options. The result is a diverse array of aromas and flavor profiles that express layered and nuanced complexity. No matter your preference, you'll find a Tequila here to match your palate.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Corbin Burnes needs Tommy John surgery. Prepare for aftershocks.
Corbin Burnes needs Tommy John surgery. Prepare for aftershocks.

Washington Post

time29 minutes ago

  • Washington Post

Corbin Burnes needs Tommy John surgery. Prepare for aftershocks.

When Arizona Diamondbacks ace Corbin Burnes left a pitch up to CJ Abrams last Sunday and immediately motioned for trainers, everyone at Chase Field understood what it might mean. And when cameras caught Burnes appearing to express concern about his elbow, there was little reason to doubt his self-diagnosis. Burnes has been one of the game's most durable starters since the start of the 2021 season. He knew this would change that. Diamondbacks Manager Torey Lovullo on Friday confirmed what Burnes and others had already suspected: The ace to whom Arizona committed $210 million over the next six years will miss the rest of the 2025 season and most of 2026 because he needs Tommy John surgery. Burnes, 30, will have the procedure next week. All injuries spur ripples — sometimes through a team's active roster, sometimes deep into an organization's minor league depth. But an injury to Burnes, one of the game's preeminent starting pitchers anchoring the rotation of a would-be playoff team fighting for its life, will have aftershocks near and far. The first jolt, of course, will be felt in the desert, where the Diamondbacks are hovering around .500 while trying to steady a pitching staff that was disappointing even with Burnes. Their other ace, Zac Gallen, has been uncharacteristically mediocre. Promising righty Brandon Pfaadt has been getting pummeled and lefty Eduardo Rodriguez only returned from injury Friday, meaning the Diamondbacks cannot be sure what he will give them. As such, if they intend to contend, they will likely need to add a starter at or before the trade deadline. Demand was already high, and with several teams still weighing their commitment to 2025, supply remains limited. But the Burnes injury could also change more than just the Diamondbacks' 2025 calculus; Arizona's owner, Ken Kendrick, has invested in winning recently but could seize the whiff of mediocrity to balance his recently bloated budget. If the Diamondbacks fall out of contention — and without Burnes, the chances of that increase — they could seek trades for first baseman Josh Naylor (making $10.9 million this year), third baseman Eugenio Suarez ($15 million), Gallen ($13.5 million) and right-hander Merrill Kelly ($7 million), all of whom would represent significant savings even with just the post-deadline portions of their salaries gone. Any savings could be crucial, because Burnes's injury also complicates Arizona's offseason. Gallen will be a free agent for the first time, and he will almost certainly want to test the market. Kelly will be a free agent, too. So is Jordan Montgomery, who also underwent Tommy John surgery this year. That leaves Arizona with only three sure things in next year's rotation: Rodriguez, Pfaadt and Ryne Nelson, who was in Arizona's bullpen but has started three games for the Diamondbacks this year. They will need more to contend in the National League West, which means they might need to be major players in this year's offseason starting pitching market, even though they just gave Burnes the largest pitching contract in their history. Fortunately for anyone seeking starting pitching this winter, options abound. Gallen, Framber Valdez and Dylan Cease headline a class that will also include Ranger Suárez, Chris Bassitt and Zach Eflin, not to mention the dozen or so strong starters who could opt out of deals if they so choose. But one more team on the prowl increases demand this winter — just like one more seller changes the entire trade deadline a few months earlier. For that reason, the aftershocks of the Burnes injury will also be felt in New York and Los Angeles and Chicago and beyond. If the Diamondbacks do decide to sell, even an underperforming Gallen would be one of the more coveted assets available — a potential fate-alterer for any postseason team. Suarez, too, offers the kind of clubhouse pep and on-field power that would make him a highly sought after deadline option. The Yankees, for example, have been hunting for a third base solution all year. Naylor has plenty of pop and postseason experience, too. Kelly has proven himself to be as tough as they come. If the Diamondbacks sell, any one of those players could change a team's October trajectory, if the stars align. Arizona is currently one of several teams that expected to contend and are underachieving. The Boston Red Sox, Atlanta Braves, Baltimore Orioles and Texas Rangers are all hoping to stave off a deadline sale by rejuvenating their chances over the next two months. The more that do so, the higher demand for Arizona's assets will be. The Diamondbacks have not been ones to cave in recent years, in large part because few teams know better how quickly fates can change. In 2023, they found themselves two games under .500 on August 11. They ended up in the World Series. But rallies like those are hard to engineer even with an annual Cy Young contender in the rotation. Without one … well, the contending vultures are starting to gather in the desert.

Has Warren Buffett made his best move ever selling his Apple stock?
Has Warren Buffett made his best move ever selling his Apple stock?

Yahoo

time30 minutes ago

  • Yahoo

Has Warren Buffett made his best move ever selling his Apple stock?

It's never a good idea trying to second-guess the Oracle of Omaha. Warren Buffett sold a huge chunk of his Apple (NASDAQ:AAPL) stock last year. It wasn't the first time he trimmed his position in the tech giant. Back in 2021, he admitted selling was 'probably a mistake'. But, amid recent share price weakness, I doubt he will repeat the same line this time. Recent soundings from Apple CEO Tim Cook seem to indicate he has taken a leaf out of Buffett's playbook. In a recent earnings call, he pushed investors to be patient as it attempts to roll out AI features in the iPhone. 'Not first, but best' was how he put it in an interview last year. In an investing landscape measured in quarterly earnings, though, many don't have much patience. In some respects, he is right. Three years into the generative AI revolution and not one consumer product has emerged, other than ChatGPT, of course. And that's despite the industry spending hundreds of billions of dollars, and with the might of the media hyping the technology on an almost daily basis. Recently, Jony Ive, the architect instrumental in the design of the iPhone, sold his company to OpenAI for $6.5bn. At the not-for-profit startup, he is working on what has been described as a 'screen-free' device. Some reports highlight that mass production could start as early as 2027. The threat is clearly on Apple's radar. During the ongoing Google anti-trust trial, one of Apple's senior executive stated: 'You may not need an iPhone 10 years from now, as crazy as that sounds.' Given the present state of hardware technology and the extremely vague statements that have come from Sam Altman regarding no-screen devices, I'm not willing to give much credence to these remarks. But, of course, that could change in the years ahead. Apple has a history of not rushing into a new technology, until its full potential is understood. It was a little-known company when General Magic invented the first smartphone. It didn't invent the music player, either. The biggest short-term risk to the stock is tariffs. Apple has undoubtedly been the biggest beneficiary of outsourcing manufacturing to China. It has certainly been a major contributor in pushing the valuation to $3trn. Trump's ambition of seeing the iPhone mass produced in the US is unlikely to ever happen, in my opinion. With consumers being squeezed from all directions these days, I don't believe they would ever stomach paying up to $3,000 for one. Tim Cook has already guided to expect $900m in additional costs over the next quarter. A tiny figure, yes, but I can't see it ending there. Without price increases, the frothy valuation looks unsustainable. As I just said, I'm not sure that consumers will be as obliging as in the past and accept such increases. As for Buffett, he still holds a significant chunk of Apple stock. But with a trailing price-to-earnings of 32, I'm not sure the risks are fully priced in. Therefore, I won't be investing. The post Has Warren Buffett made his best move ever selling his Apple stock? appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Andrew Mackie has no position in any of the shares mentioned. The Motley Fool UK has recommended Apple. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store